, Ainsi il est crucial d'identifier ces engagements et puis essayer d'être innovant tout en les considérants. De plus, il y a un grand besoin ; celui de l'engagement de la part du management sur des stratégies d'innovation. Sans quoi, rien n'avancera vraiment. Les personnes peuvent être divisées en plusieurs catégories

I. Bojanova, The Digital Revolution: What's on the Horizon, IT Professional, vol.16, issue.1, pp.8-12, 2014.

M. Settembre, Towards a Hyper-Connected World, 2012.

«. Le and . De, Toute résistance est inutile, vous serez assimilés ! »-Claude Molly-Mitton USF, 2015.

R. V. Milani, C. J. Et, and . Lavie, « Health Care 2020: Reengineering Health Care Delivery to Combat Chronic Disease, The American Journal of Medicine, vol.128, issue.4, pp.337-380, 2015.

P. Rubel, J. Fayn, L. Simon-chautemps, H. Atoui, M. Ohlsson et al., New Paradigms in Telemedicine: Ambient Intelligence, Wearable, Pervasive and Personalized, vol.108, pp.123-155, 2005.

N. Zadbuke, S. Shahi, B. Gulecha, A. Padalkar, M. Et et al.,

, « Recent trends and future of pharmaceutical packaging technology, Journal of Pharmacy & Bioallied Sciences, vol.5, issue.2, pp.98-110, 2013.

F. Pene, E. Courtine, A. Cariou, and J. Mira, Critical Care Medicine, vol.37, pp.50-58, 2009.

A. Hatchuel and P. L. Masson, « From R&D to RID: Design strategies and the management of innovation fields

. Innovations-technologique, P. M. Au-sein-de, and . Innovantes, Complémentarité des processus, analyse comparative des mécanismes de diffusion. Cécile Ayerbe-machat-XIIème conférence de l'association Internationale de Management stratégique, 2003.

, Global Health Observatory-World Health Statistic, 2014.

M. Holy, G. Schmidt, W. Et, and . Schröder, « Potential Malaria Outbreak in Germany due to Climate Warming: Risk Modelling Based on Temperature Measurements and Regional Climate Models ». Environmental Science and Pollution Research International 18, pp.428-463, 2011.

Y. T. Zhang, Y. S. Yan, and C. C. Poon, « Some Perspectives on Affordable Healthcare Systems in China, Annual International Conference of the IEEE Engineering in Medicine and Biology Society, p.6155, 2007.

R. H. Osborne, J. M. Spinks, and I. P. Wicks, « Patient Education and Self-Management Programs in Arthritis », Medical Journal of Australia, vol.180, pp.23-26, 2004.

P. J. Declerck, Biologicals and biosimilars: a review of the science and its implications, Generics and Biosimilars Initiative Journal (GaBI J), vol.1, issue.1, pp.13-19, 2012.

C. K. Schneider, P. Celis, P. Salmikangas, M. Figuerola-santos, L. D'apote et al., Challenges with Advanced Therapy Medicinal Products and How to Meet Them, vol.9, pp.195-201, 2010.

K. M. Gartland, F. Bruschi, M. Dundar, P. B. Gahan, M. Viola-magni et al., Progress towards the "Golden Age" of Biotechnology, vol.24, pp.6-13, 2013.

D. Brar, Rapport de synthèse-Bioproduction, Etat des lieux et recommendation pour l'attractivité de la France-Leem Biotech & Genolpole / Developpement et conseil, 2008.

A. J. Thrasher, H. B. Salima-hacein-bey-abina, S. Gaspar, E. G. Blanche, K. Davies et al., « Failure of SCID-X1 Gene Therapy in Older Patients, Blood, vol.105, issue.11, pp.4255-57

. Cavazzana-calvo, A. Marina, and . Fischer, « Gene Therapy for Severe Combined Immunodeficiency: Are We There Yet?, The Journal of Clinical Investigation, vol.117, issue.6, pp.1456-65, 2007.

D. Taura, M. Noguchi, M. Sone, K. Hosoda, E. Mori et al., Adipogenic Differentiation of Human Induced Pluripotent Stem Cells: Comparison with that of Human Embryonic Stem Cells, FEBS Letters, vol.583, issue.6, pp.1029-1062

P. Benkimoun, Première mondiale: Des cellules au secours du coeur »-Le monde

, Transparency Committee Opinion, Chondrocelect"-HAS, vol.29, 2013.

V. Shankaran, H. Ikeda, A. T. Bruce, J. M. White, P. E. Swanson et al., « IFNgamma and Lymphocytes Prevent Primary Tumour Development and Shape Tumour Immunogenicity », Nature, vol.410, pp.1107-1118, 2001.

I. H. Koumakpayi, C. L. Page, A. Mes-masson, and E. F. Saad, « Hierarchical Clustering of Immunohistochemical Analysis of the Activated ErbB/PI3K/Akt/NF-kappaB Signalling Pathway and Prognostic Significance in Prostate Cancer, British Journal of Cancer, vol.102, issue.7, pp.1163-73

M. Cynober, Le marché des dispositifs médicaux »-Agence d'intelligence économique, 2011.

, UV-sensor, minimize sun damage and track sun-generated vitamin D

S. Darma, DNA Nanorobot developed for future immune responses programming, Medgadget.com, 2012.

B. Jiang, . Et-bingyun, and . Li, « Polypeptide Nanocoatings for Preventing Dental and Orthopaedic Device-Associated Infection: pH-Induced Antibiotic Capture, Release, and Antibiotic Efficacy, Journal of Biomedical Materials Research. Part B, Applied Biomaterials, vol.88, issue.2, pp.332-370, 2009.

R. Kannangai, A. M. Abraham, S. Sankar, and G. Sridharan, « Nanotechnology Tools for Single-Virus Particle Detection, Indian Journal of Medical Microbiology, vol.28, issue.2, pp.95-99, 2010.

. Boulaiz, P. J. Houria, A. Alvarez, J. A. Ramirez, J. Marchal et al., Consolación Melguizo, et Antonia Aranega. « Nanomedicine: Application Areas and Development Prospects, International Journal of Molecular Sciences, vol.12, issue.5, pp.3303-3324, 2011.

A. Atala, R. Lanza, R. Nerem, and J. A. Thomson, Principles of Regenerative Medicine, pp.733-1105, 2011.

Z. A. Nur-hanani, Y. H. Roos, and J. P. Kerry, « Use and Application of Gelatin as Potential Biodegradable Packaging Materials for Food Products, International Journal of Biological Macromolecules, vol.71, pp.94-102, 2014.

P. Dobson, Theranostics: A combination of diagnostics and therapy

, Jérôme Topsent | Galderma R&D-Year, 201566.

M. Caselli, F. Cassol, G. Calò, J. Holton, G. Zuliani et al., « Actual concept of "probiotics": Is it more functional to science or business?, World Journal of Gastroenterology : WJG, vol.19, issue.10

H. H. Kong, J. A. Et, and . Segre, « Skin Microbiome: Looking back to Move Forward, The Journal of Investigative Dermatology, vol.132, issue.2, pp.933-972, 2012.

W. Bowe, N. B. Patel, and A. C. Logan, Acne Vulgaris, Probiotics and the Gut-Brain-Skin Axis: From Anecdote to Translational Medicine, vol.5, pp.185-99

K. Dobos, Cosmetic drug or cosmeceutical-What is the difference

M. Chua, T. C. Baldwin, T. J. Hocking, and K. Chan, « Traditional Uses and Potential Health Benefits of, Journal of Ethnopharmacology, vol.128, issue.2, pp.268-78

A. Schuhmacher, P. Germann, H. Trill, and O. Gassmann, « Models for Open Innovation in the Pharmaceutical Industry. » Drug Discovery Today 18, pp.1133-1170, 2013.

, Philippes Iberzahn, analyse du live « Immunity to change

, Juillet, 2015.

B. Pascal-le-masson, A. Weil, and . Hatchuel, « From R&D to RID », 8th IPDM conference, 2001.

, Faut-il encore investor en R&D

, The Evolution of Open Innovation: An Interview with Henry Chesbrough :: Open Innovation Community

H. Chesbrough, Open Innovation: The New Imperative for Creating and Profiting from Technology, 2003.

, Jérôme Topsent | Galderma R&D-Year, 2015.

, Antibody-Nature images

. Ultraviolet,

, Code-Source: Google bank of images-Free label for use consulted the

, Vision tools & Google glass-Source: Google bank of images-Free label

, In a context of digital (r)evolution and hyperconnectivity, where is innovation in healthcare?

, Jérôme Topsent | Galderma R&D-Year, 2015.

, Filler of tomorrow-Source: Google bank of images-Free label for use consulted the